SOLASTO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 464 JPY | +0.43% |
|
-1.07% | -24.68% |
| Apr. 22 | Solasto's Occupancy Rate Slips in March | MT |
| Mar. 21 | Solasto's Number of Facility Residents Up Nearly 14.7% in February | MT |
| Sales 2024 | 135B 859M | Sales 2025 * | 144B 915M | Capitalization | 42.79B 272M |
|---|---|---|---|---|---|
| Net income 2024 | 2.26B 14.34M | Net income 2025 * | 3.7B 23.51M | EV / Sales 2024 | 0.47 x |
| Net Debt 2024 | 13.4B 85.13M | Net Debt 2025 * | 10.8B 68.61M | EV / Sales 2025 * | 0.37 x |
| P/E ratio 2024 |
22.9
x | P/E ratio 2025 * |
11.5
x | Employees | 31,982 |
| Yield 2024 |
3.63% | Yield 2025 * |
4.31% | Free-Float | 53.02% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.43% | ||
| 1 week | -1.07% | ||
| 1 month | -6.83% | ||
| 3 months | -13.43% | ||
| 6 months | -20.95% | ||
| Current year | -24.68% |
1 week
445.00
468.00
1 month
445.00505.00
Current year
445.00624.00
1 year
445.00710.00
3 years
445.001 600.00
5 years
445.001 681.00
10 years
304.001 681.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mitsuhiro Okada
DFI | Director of Finance/CFO | - | 19-12-31 |
Naoki Yoshida
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tsutomu Une
BRD | Director/Board Member | 76 | 16-05-31 |
Masumi Tamai
BRD | Director/Board Member | 63 | 85-04-30 |
Kanitsu Uchida
BRD | Director/Board Member | 59 | 19-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 19 M€ | +7.38% | ||
| 0.01% | 17 M€ | +14.54% | - | |
| 0.01% | 140,441 M€ | +19.22% | ||
| 0.01% | 63,295 M€ | +18.52% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 464 | +0.43% | 2,093,200 |
| 24-05-30 | 462 | +1.09% | 471,200 |
| 24-05-29 | 457 | -0.65% | 317,300 |
| 24-05-28 | 460 | -0.43% | 273,400 |
| 24-05-27 | 462 | -1.49% | 490,000 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
Solasto Corp is a Japan-based company mainly engaged in the medical-related contract business, and the nursing care and childcare business. The Company has two business segments. The Medical Related Contract segment is engaged in the provision of contract and staffing services such as reception, accounting, medical fee billing, hospital management support and other medical office related services. The Nursing Care And Childcare segment is engaged in the provision of home help services, day services, paid nursing homes with long-term care services, care houses, residential-type paid elderly homes, home care support services, group homes, home-visit nursing care services, childcare services, as well as the rental and sale of welfare equipment. The Company is also engaged in the provision of education and training services such as medical and nursing care related courses, the skill certification test business, the real estate leasing business, and the insurance agency business.
Calendar
2024-08-06
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
464
JPY
Average target price
770
JPY
Spread / Average Target
+65.95%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.68% | 272M | |
| +25.52% | 88.99B | |
| -24.52% | 74.82B | |
| -5.56% | 25.03B | |
| +4.31% | 17.88B | |
| -14.25% | 16.43B | |
| +2.97% | 15.77B | |
| +70.11% | 13.09B | |
| +79.20% | 13.21B | |
| +40.44% | 12.9B |
- Stock Market
- Equities
- 6197 Stock
